Profil
Leonard M.C.
Firestone is Chief Executive Officer of Hawaii Biotech, Inc. Previously, he was Chief Executive Officer, President, Chief Medical Officer and a Director of Manhattan Pharmaceuticals, Inc. from 2003 to 2005, Chief Executive Officer, Chief Medical Officer and a Director of Innovative Drug Delivery Systems, Inc., now Intrac, Inc. from 2001 to 2003 and Chief Executive Officer and Chairman of University Anesthesiology and the Critical Care Medicine Foundation from 1996 to 2001.
Prior to that, he was Chief Executive Officer and a Director of Avantogen Ltd.
Dr. Firestone received an MD degree from Yale University.
Ehemalige bekannte Positionen von Leonard M. C. Firestone
Unternehmen | Position | Ende |
---|---|---|
TG THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
Innovative Drug Delivery Systems, Inc.
Innovative Drug Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology IDDS is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical need in the pain management market. IDDS’s product candidates address the market segment for prescription medications focused on treating acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post operative pain, orthopedic injury, procedural pain, burn pain and trauma. The product candidates offer enhanced pain relief, fewer adverse side effects and faster relief of pain compared to other currently available treatments. | Präsident | 01.01.2003 |
Acuvax Ltd.
Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | Präsident | - |
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TG THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Health Technology |
Innovative Drug Delivery Systems, Inc.
Innovative Drug Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology IDDS is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical need in the pain management market. IDDS’s product candidates address the market segment for prescription medications focused on treating acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post operative pain, orthopedic injury, procedural pain, burn pain and trauma. The product candidates offer enhanced pain relief, fewer adverse side effects and faster relief of pain compared to other currently available treatments. | Health Technology |
Acuvax Ltd.
Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | Health Technology |